Anti-Snoring Treatment Devices

Global Anti-Snoring Treatment Devices Market to Reach US$2.2 Billion by 2030

The global market for Anti-Snoring Treatment Devices estimated at US$1.5 Billion in the year 2024, is expected to reach US$2.2 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. CPAP Devices, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$1.0 Billion by the end of the analysis period. Growth in the Mandible Advancement Devices segment is estimated at 7.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$396.5 Million While China is Forecast to Grow at 11.8% CAGR

The Anti-Snoring Treatment Devices market in the U.S. is estimated at US$396.5 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$478.5 Million by the year 2030 trailing a CAGR of 11.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 7.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.0% CAGR.

Global Anti-Snoring Treatment Market – Key Trends & Drivers Summarized

What Is Driving the Growing Demand for Anti-Snoring Treatment?
The anti-snoring treatment market has been expanding due to the rising prevalence of sleep-related breathing disorders such as obstructive sleep apnea (OSA) and habitual snoring. The increasing awareness of the adverse health effects associated with snoring, including cardiovascular diseases, hypertension, and daytime fatigue, has led individuals to seek effective treatment solutions. Lifestyle changes, such as increased obesity rates and sedentary habits, have further exacerbated snoring issues, increasing the demand for treatment options. Moreover, the rising elderly population, which is more prone to snoring-related complications, has contributed to the growing market. Technological advancements in anti-snoring devices, including CPAP machines, oral appliances, and minimally invasive surgical interventions, have further fueled market expansion.

How Are Innovations and Product Advancements Shaping the Market?
The market has seen continuous innovation with the introduction of wearable anti-snoring devices, smart sleep monitors, and AI-powered diagnostic tools that help individuals track and mitigate snoring. The growing adoption of non-invasive treatment options, such as positional therapy and nasal dilators, has gained popularity among consumers seeking convenient solutions. Additionally, developments in surgical interventions, including radiofrequency ablation and palatal implants, have offered long-term relief for chronic snorers. Pharmaceutical companies are also investing in nasal sprays and anti-snoring medications that target the root causes of snoring, such as nasal congestion and muscle relaxation. The integration of digital health platforms for remote diagnosis and personalized treatment plans has further enhanced patient accessibility to effective anti-snoring solutions.

Why Is Consumer Awareness and Market Accessibility Expanding?
The growing emphasis on sleep hygiene and overall wellness has significantly contributed to the expansion of the anti-snoring treatment market. Public health initiatives and awareness campaigns highlighting the risks associated with untreated snoring and sleep apnea have encouraged individuals to seek medical intervention. The increasing availability of over-the-counter (OTC) anti-snoring solutions has also facilitated greater market penetration, particularly among individuals seeking cost-effective treatments. The rise of e-commerce platforms has further improved accessibility, enabling consumers to explore and purchase a wide range of anti-snoring products from the comfort of their homes. Furthermore, partnerships between healthcare providers and device manufacturers have improved treatment adherence, ensuring that patients receive customized solutions based on their specific needs.

What Are the Key Growth Drivers of the Anti-Snoring Treatment Market?
The growth in the anti-snoring treatment market is driven by several factors, including the rising prevalence of sleep disorders, increasing healthcare expenditure, and advancements in medical technology. The expanding insurance coverage for sleep-related treatments has encouraged more individuals to seek professional care. The increasing research on genetic and lifestyle-related factors contributing to snoring has led to more targeted treatment approaches. The demand for innovative, minimally invasive solutions has pushed manufacturers to develop more effective and user-friendly devices. Additionally, the integration of artificial intelligence and machine learning in sleep diagnostics has improved early detection and treatment planning. The growing geriatric population, along with the surge in awareness regarding the impact of poor sleep on overall health, has further fueled market expansion. Finally, regulatory support for the approval of new anti-snoring therapies and devices has enhanced the availability of advanced treatment solutions worldwide.

SCOPE OF STUDY:

The report analyzes the Anti-Snoring Treatment Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Device Type (CPAP Devices, Mandible Advancement Devices, Nasal Devices, Tongue Stabilizing Devices, Chin Straps, Other Device Types); Distribution Channel (Hospital and Clinic Pharmacies, Retail Pharmacies, Online Distribution Channel, Other Distribution Channels)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

• Airing, Inc.
• Apnea Sciences Corporation
• Fisher & Paykel Healthcare
• Illusion Aligners
• Nidra Care
• Nyxoah SA
• ResMed, Inc.
• Sleeping Well, LLC dba ZQuiet
• SomnoMed, Inc
• Somnowell Ltd
• The Pure Sleep Company

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.